Founding Year2015TractionTempus has shown strong revenue growth, reaching $531 million in 2023. The company is focused on genomic testing and data analysis in the healthcare sector.Revenue Amount$531,000,000Organizations InvolvedNEA, Revolution Growth, T. Rowe Price, Novo Holdings, Franklin Templeton, Baillie Gifford, SoftBankFoundersEric LefkofskyMarketHealthcareLocationChicago, IL, USCoinvestorsNEA, Revolution Growth, T. Rowe Price, Novo Holdings, Franklin Templeton, Baillie Gifford, SoftBank Company Description
Tempus is a genomic testing and data analysis company founded by Eric Lefkofsky in 2015. The company focuses on applying technology to cancer care to help physicians make data-driven decisions. Tempus has shown significant revenue growth, reaching $531 million in 2023, with a focus on genomic testing and data analysis in the healthcare sector.